Leading Edge Financial Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,259
Closed -$233K 66
2023
Q3
$233K Sell
2,259
-23
-1% -$2.48K 0.15% 59
2023
Q2
$263K Buy
2,282
+251
+12% +$28.5K 0.17% 54
2023
Q1
$216K Buy
2,031
+8
+0.4% +$864 0.16% 63
2022
Q4
$224K Buy
+2,023
New +$207K 0.19% 60

Other funds holding MRK

Leading Edge Financial Planning's MRK Position: Q4 2023 in Review

Leading Edge Financial Planning sold out of Merck (MRK) in Q4 2023, closing a stake of 2,259 shares — an estimated $233K sold.

Leading Edge Financial Planning first reported a position in MRK in Q4 2022 and held it in 4 quarters. The position peaked at $263K in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Leading Edge Financial Planning reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Leading Edge Financial Planning sold 2,259 Merck shares in Q4 2023, an estimated $233K.
  • Leading Edge Financial Planning first reported a position in Merck in Q4 2022 and held it in 4 quarters.
  • Leading Edge Financial Planning's Merck position peaked at $263K in Q2 2023.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Leading Edge Financial Planning's 13F filing for Q4 2023, filed 13 Feb 2024.